Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 10, 2026.
The Healthcare company reported Q0 revenue of .
Sonoma Pharmaceuticals, Inc.'s stock currently trades at $2.81 with a market capitalization of $6.3M.


